Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor Faheez MohamedO. Anthony StuartPaul H. Sugarbaker Original Article 14 April 2006 Pages: 719 - 724
Efficacy of 2-halogen substituted d-glucose analogs in blocking glycolysis and killing “hypoxic tumor cells” Theodore J. LampidisMetin KurtogluWaldemar Priebe Original Article 23 March 2006 Pages: 725 - 734
Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer Yoshinobu IwasakiShuji OhsugiTsunehiko Nishimura Original Article 25 March 2006 Pages: 735 - 741
Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study Alexandros ArdavanisDimitris Mavroudisfor the Breast Cancer Committee of the Hellenic Oncology Research Group (HORG) Original Article 23 May 2006 Pages: 742 - 748
Screening of an annotated compound library for drug activity in a resistant myeloma cell line Linda RickardsonMårten FryknäsRolf Larsson Original Article 10 March 2006 Pages: 749 - 758
A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer Tomislav DragovichDavid MendelsonAxel Hoos Original Article 23 May 2006 Pages: 759 - 764
Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells Z. ShafaeeH. SchmidtR. Weichselbaum Original Article 22 March 2006 Pages: 765 - 770
Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase Muhammad Wasif SaifGlenda BlackRobert Diasio Original Article 22 March 2006 Pages: 771 - 775
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene Xianrang SongXianxi LiuJinming Yu Original Article 11 March 2006 Pages: 776 - 784
Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel Kohji TakaraYukihisa ObataTeruyoshi Yokoyama Original Article 14 March 2006 Pages: 785 - 793
Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin Wataru IchikawaAkio OoyamaRenzo Hirayama Original Article 10 March 2006 Pages: 794 - 801
Protection against cisplatin-induced nephrotoxicity by Spirulina in rats Iyyapu Krishna MohanMahmood KhanVijay Kumar Kutala Original Article 22 March 2006 Pages: 802 - 808
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer Hugo E. R. FordYoon-Sim YapStephen R. D. Johnston Original Article 10 March 2006 Pages: 809 - 815
Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin Mohammad Al-FayezHong CaiAndreas J. Gescher Original Article 22 March 2006 Pages: 816 - 825
Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolates Eran BramIlan IferganYehuda G. Assaraf Original Article 13 April 2006 Pages: 826 - 834
Panmucositis and chemosensitisation associated with betel quid chewing during dose-dense adjuvant breast cancer chemotherapy Richard J. EpsteinThomas W. T. LeungPolly S. Y. Cheung Short Communication 11 March 2006 Pages: 835 - 837
Can similar oral blood exposures between studies result in a different bioavailability? Christian Puozzo Letter to the Editors 24 March 2006 Pages: 838 - 841
Extraocular sebaceous carcinoma in Muirr Torre Syndrome with unfavorable prognosis A. De LeoD. InnocenziN. Scuderi Letter to the Editors 13 May 2006 Pages: 842 - 844